Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women

Osteoarthritis and Cartilage

Volumn 24, Issue 4, 2016, Pages 672-678

  Runhaar, J ^a,b   Sanchez, C ^b,c   Taralla, S ^d   Henrotin, Y ^b,c   Bierma Zeinstra, S M A ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b D BOARD Consortium   (United Kingdom)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Artialis SA   (Belgium)

Author keywords

Biomarker; Fibulin 3; Osteoarthritis (OA); Serum

Indexed keywords

BIOLOGICAL MARKER; FIBULIN; FIBULIN 3; UNCLASSIFIED DRUG; EFEMP1 PROTEIN, HUMAN; EPITOPE; PEPTIDE FRAGMENT; SCLEROPROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHRONIC PAIN; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JOINT SPACE NARROWING; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MIDDLE AGED; MUSCULOSKELETAL SYSTEM PARAMETERS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; IMMUNOASSAY; IMMUNOLOGY; OSTEOARTHRITIS, KNEE; PROCEDURES; PROGNOSIS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

BIOMARKERS; BODY MASS INDEX; EPITOPES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; MIDDLE AGED; OBESITY; OSTEOARTHRITIS, KNEE; OVERWEIGHT; PEPTIDE FRAGMENTS; PROGNOSIS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

EID: 84960327066     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.10.013     Document Type: Article

References (26)

1. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707. 10.1002/art.34453.
2. van Spil W.E., DeGroot J., Lems W.F., Oostveen J.C., Lafeber F.P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18:605-612. 10.1016/j.joca.2010.01.012.
3. Henrotin Y., Addison S., Kraus V., Deberg M. Type II collagen markers in osteoarthritis: what do they indicate?. Curr Opin Rheumatol 2007, 19:444-450. 10.1097/BOR.0b013e32829fb3b5.
4. Golightly Y.M., Allen K.D., Helmick C.G., Schwartz T.A., Renner J.B., Jordan J.M. Hazard of incident and progressive knee and hip radiographic osteoarthritis and chronic joint symptoms in individuals with and without limb length inequality. J Rheumatol 2010, 37:2133-2140. 10.3899/jrheum.091410.
5. Kraus V.B., Burnett B., Coindreau J., Cottrell S., Eyre D., Gendreau M., et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 2011, 19:515-542. 10.1016/j.joca.2010.08.019.
6. Ehlermann J., Weber S., Pfisterer P., Schorle H. Cloning, expression and characterization of the murine Efemp1, a gene mutated in Doyne-Honeycomb retinal dystrophy. Gene Expr Patterns 2003, 3:441-447. 10.1016/S1567-133X(03)00084-X.
7. Albig A.R., Neil J.R., Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 2006, 66:2621-2629. 10.1158/0008-5472.CAN-04-4096.
8. Klenotic P.A., Munier F.L., Marmorstein L.Y., Anand-Apte B. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J Biol Chem 2004, 279:30469-30473. 10.1074/jbc.M403026200.
9. Djokic J., Fagotto-Kaufmann C., Bartels R., Nelea V., Reinhardt D.P. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J Biol Chem 2013, 288:22821-22835. 10.1074/jbc.M112.439158.
10. Henrotin Y., Gharbi M., Mazzucchelli G., Dubuc J.E., De Pauw E., Deberg M. Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum 2012, 64:2260-2267. 10.1002/art.34392.
11. de Vos B.C., Runhaar J., Bierma-Zeinstra S.M. Effectiveness of a tailor-made weight loss intervention in primary care. Eur J Nutr 2014, 53:95-104. 10.1007/s00394-013-0505-y.
12. Runhaar J., van Middelkoop M., Reijman M., Willemsen S., Oei E.H., Vroegindeweij D., et al. Prevention of knee osteoarthritis in overweight females; the first preventive randomized controlled trial in osteoarthritis. Am J Med 2015, 128:888-895. 10.1016/j.amjmed.2015.03.006.
13. Buckland-Wright J.C., Wolfe F., Ward R.J., Flowers N., Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. J Rheumatol 1999, 26:2664-2674.
14. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
15. Lequesne M. Quantitative measurements of joint space during progression of osteoarthritis: chondrometry. Osteoarthritic Disorders 1995, 427-444. Rosemont: American Academy of Orthopaedic Surgeons. K. Kuettner, V. Goldberg (Eds.).
16. Kraus V.B., Vail T.P., Worrell T., McDaniel G. A comparative assessment of alignment angle of the knee by radiographic and physical examination methods. Arthritis Rheum 2005, 52:1730-1735. 10.1002/art.21100.
17. Lean M.E., Han T.S., Deurenberg P. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr 1996, 63:4-14.
18. Wendel-Vos G.C., Schuit A.J., Saris W.H., Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003, 56:1163-1169. 10.1016/S0895-4356(03)00220-8.
19. Roos E.M., Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 2003, 1:17. 10.1186/1477-7525-1-17.
20. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum 1986, 29:1039-1049.
21. Halper J., Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol 2014, 802:31-47. 10.1007/978-94-007-7893-1_3.
22. Sharma L., Lou C., Felson D.T., Dunlop D.D., Kirwan-Mellis G., Hayes K.W., et al. Laxity in healthy and osteoarthritic knees. Arthritis Rheum 1999, 42:861-870. 10.1002/1529-0131(199905)42:5.
23. Sharma L., Eckstein F., Song J., Guermazi A., Prasad P., Kapoor D., et al. Relationship of meniscal damage, meniscal extrusion, malalignment, and joint laxity to subsequent cartilage loss in osteoarthritic knees. Arthritis Rheum 2008, 58:1716-1726. 10.1002/art.23462.
24. Miura H., Takasugi S., Kawano T., Manabe T., Iwamoto Y. Varus-valgus laxity correlates with pain in osteoarthritis of the knee. Knee 2009, 16:30-32. 10.1016/j.knee.2008.09.003.
25. Aunan E., Kibsgard T.J., Diep L.M., Rohrl S.M. Intraoperative ligament laxity influences functional outcome 1 year after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2014, 10.1007/s00167-014-3108-0.
26. Bauer D.C., Hunter D.J., Abramson S.B., Attur M., Corr M., Felson D., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006, 14:723-727. 10.1016/j.joca.2006.04.001.